University of Michigan: Parkinson Disease trials

The registry lists 23 Parkinson Disease studies with University of Michigan as lead sponsor. 3 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 4Phase 4 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD MutationRecruitingNCT07642908
• A Pilot Study of In-lab Dynamic Standing in Parkinson's DiseaseRecruitingNCT07543861Phase 1
• Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)Not yet recruitingNCT05509842Not applicable
• Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's DiseaseCompletedNCT05948956Not applicableResults posted
• Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: KetonesTerminatedNCT05778695Not applicableResults posted
• Development of a Multifunctional Rehabilitation Device for Persons With Parkinson's DiseaseCompletedNCT05586490Not applicableResults posted
• Vigor and the LDR in Parkinson DiseaseCompletedNCT04821830Phase 4Results posted
• Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])CompletedNCT04403399Phase 2Results posted
• Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil ArmCompletedNCT03462641Phase 1/2Results posted
• Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3CompletedNCT02933372Phase 2Results posted
• Transcutaneous Vibro-Acoustic Therapy in Parkinson DiseaseTerminatedNCT05962476Not applicable
• Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)Active, not recruitingNCT05459753Not applicable
• Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson DiseaseCompletedNCT05446194Not applicable
• Citalopram as a Posterior Cortical Protective Therapy in Parkinson DiseaseCompletedNCT04497168Phase 2
• Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson DiseaseCompletedNCT03045211Not applicable
• Serotonin and AmyloidopathyCompletedNCT02895932Not applicable
• Cholinergic Mechanisms of Gait Dysfunction in Parkinson's DiseaseCompletedNCT02458430
• Cholinergic Nicotinic Receptors and Cognition in PDCompletedNCT02076295
• Amyloid Beta and Cognition in Parkinson DiseaseCompletedNCT01754168
• Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's DiseaseCompletedNCT01572142
• PET Study of Non-Motor Symptoms of Parkinson DiseaseCompletedNCT01565473
• Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's DiseaseCompletedNCT00737217
• Striatal and Extra-striatal Mechanisms of Falling in Parkinson's DiseaseCompletedNCT00736671